Skip to main content
. 2020 Nov 20;100(8):2015–2022. doi: 10.1007/s00277-020-04350-6

Fig. 2.

Fig. 2

Probability of recurrence-free survival: the cumulative probability of the ATE/VTE recurrence-free survival in 71 MPN patients treated with DOAC (n = 26, red curve) or VKA (n = 45, blue curve) was statistically not significantly different (p = 0.2)